Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Investor	Date	% Owned	Market Value	Shares	Chg. Shares	Chg. Shares %	% Portfolio
The Vanguard Group, Inc.	2025-10-31	4.09139%	CHF 9.01B	34.8M	116.0K	0.3%	0.2%
BlackRock, Inc.	2025-11-28	4.01986%	CHF 8.85B	34.2M	633.4K	1.9%	0.2%
UBS Asset Management AG	2025-07-31	3.5987%	CHF 7.92B	30.6M	-53.6K	-0.2%	0.9%
Government Pension Fund Global	2025-06-30	2.11354%	CHF 4.65B	18.0M	—	—	0.5%
Norges Bank Investment Management	2025-06-30	2.11354%	CHF 4.65B	18.0M	—	—	0.5%
Vanguard STAR Funds - Vanguard Total International Stock ETF
Massachusetts Financial Services Company
Vanguard Tax-Managed Funds - Vanguard FTSE Developed Markets ETF
Geode Capital Management, LLC
Dodge & Cox
Vanguard Fiduciary Trust Company Institutional Total International Stock Market Index Trust II
Deutsche Asset & Wealth Management
iShares Trust - iShares Core MSCI EAFE ETF
Fidelity International Ltd
UBS (CH) Index Fund - Equities Switzerland All NSL
Zürcher Kantonalbank
Melchior Oeri
JP Morgan Asset Management
Flossbach von Storch SE
Teachers Insurance and Annuity Association-College Retirement Equities Fund

Roche Holding AG

Top Holders